Publications Office of the EU
Spain-Badajoz: Pharmaceutical products - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

Spain-Badajoz: Pharmaceutical products

Overview
  • Awarded
    22/06/2021
  • Today
    05/08/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Gerencia del Área de Salud de Badajoz
Place of performance
NUTS code: ES431 Badajoz
Location of buyer
NUTS code: ES431 Badajoz
Business sector (Main CPV)
33600000 Pharmaceutical products
Total estimated contract value (excluding VAT)
560,208.83
Total final contract value (excluding VAT)
560,208.83 EUR
Procedure details
Tender reference number
CS/01/C000001350/21/PNSP
Description

Suministros por exclusividad del medicamento Adalimumab (Humira) 40 mg pluma prec 0,4 ml con destino a las farmacias hospitalarias del Área de Salud de Badajoz.

Submission Method
Not available
Tenders may be submitted
Not applicable
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Not available
Place of performance
ES431 Badajoz
CPV code

33600000 - Pharmaceutical products

Award method
Lowest price
Estimated value
560,208.83
Final contracted value
560,208.83 EUR
Award of contract
Official name: Abbvie Spain, S.L.U.
Postal address: Avenida de Burgos 91
Town: Madrid
Postal code: 28050
Country: ESP
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.